New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.
Oncotarget
; 7(41): 66769-66775, 2016 Oct 11.
Article
in En
| MEDLINE
| ID: mdl-27564257
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
/
Plantas_medicinales
Main subject:
Prostatitis
/
Signal Transduction
/
Chemokine CCL2
/
Curcumin
Type of study:
Prognostic_studies
Language:
En
Journal:
Oncotarget
Year:
2016
Type:
Article
Affiliation country:
United States